MARK2 and leukemia: PIM1 is a serine/threonine kinase known to act as an oncogene in multiple cancers, such as leukemia, myeloma, breast and prostate cancers, by phosphorylating target proteins involved in apoptosis, cell cycle progression, migration, and metabolism (48).